FINAL ANALYSIS OF GLOBAL SURVIVAL OF THE FIRST TEST IN PATIENTS WITH MULTIPLE NEW DIAGNOSTIC MYELOMA

被引：0

作者：

Oriol, A. ^{[1
]}

Facon, T. ^{[2
]}

Dimopoulos, M. ^{[3
]}

Dispenzieri, A. ^{[4
]}

Cavo, M. ^{[5
]}

Weisel, K. ^{[6
]}

Ludwig, H. ^{[7
]}

Delforge, M. ^{[8
]}

Geraldes, C. ^{[9
]}

Lee, J. J. ^{[10
]}

Chen, C. ^{[11
]}

De La Rubia, J. ^{[12
]}

White, D. ^{[13
]}

Binder, D. ^{[14
]}

Lu, J. ^{[15
]}

Kenneth, Anderson C. ^{[16
]}

Moreau, P. ^{[17
]}

Attal, M. ^{[18
]}

Fermand, J. P. ^{[19
]}

Loiseau, Avet H. ^{[20
]}

Haynes, Ervin A. ^{[21
]}

Chen, G. ^{[21
]}

Houck, V ^{[21
]}

Hulin, C. ^{[22
]}

Benboubker, L. ^{[23
]}

机构：

[1] Hosp Badalona Germans Trias & Pujol, ICO, Inst Josep Carreras, Badalona, Spain

[2] Hop Claude Huriez, Serv Malad Sang, Lille, France

[3] Univ Athens, Sch Med, Atenas, Greece

[4] Mayo Clin, Rochester, MN USA

[5] Bologna Univ, Sch Med, Seragnoli Inst Hematol, Bologna, Italy

[6] Univ Tubingen, Tubingen, Germany

[7] Wilhelminenspital Stadt Wien, Wilhelminen Canc Res Inst, Dept Med, Ctr Oncol Hematol & Palliat Care, Viena, Austria

[8] UZ Leuven, Dept Hematol, Leuven, Belgium

[9] Hosp Univ Coimbra, Coimbra, Portugal

[10] Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun Gun, Jeollanamdo, South Korea

[11] Princess Margaret Canc Ctr, Toronto, ON, Canada

[12] Hosp Univ & Politecn La Fe, Valencia, Spain

[13] Dalhousie Univ, QEII Hlth Sci Ctr, Halifax, NS, Canada

[14] Kantonsspital Winterthur, Winterthur, Switzerland

[15] Peking Univ, Peoples Hosp, Inst Hematol, Beijing, Peoples R China

[16] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA

[17] Univ Nantes, Nantes, France

[18] Inst Univ Canc Toulouse Oncopole, Toulouse, France

[19] Hop St Louis, Paris, France

[20] CHU Rangueil, Unite Genom Myelome, Toulouse, France

[21] Celgene Corp, Summit, NJ USA

[22] Bordeaux Hosp Univ Ctr CHU, Bordeaux, France

[23] CHU Tours, Hop Bretonneau, Tours, France

来源：

HAEMATOLOGICA | 2017年 / 102卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

CO-015

引用

页码：15 / 16

页数：2

共 50 条

[41] Clinical features and survival of Chilean patients with multiple myeloma
Guillermo, Conte L.
Gaston, Figueroa M.
Vivianne, Lois V.
Maria, Elena Cabrera C.
Alvaro, Leon R.
Hernan, Garcia L.
Hernan, Rojas R.
REVISTA MEDICA DE CHILE, 2007, 135 (09) : 1111 - 1117
[42] Impact of thalidomide on survival of patients with multiple myeloma.
Fawaz, A
Magro, L
Leleu, X
Depil, S
Guillerm, G
Corm, S
Bauters, F
Facon, T
Yakoub-Agha, I
BLOOD, 2002, 100 (11) : 384B - 384B
[43] Prediagnosis dietary pattern and survival in patients with multiple myeloma
Lee, Dong Hoon
Fung, Teresa T.
Tabung, Fred K.
Marinac, Catherine R.
Devore, Elizabeth E.
Rosner, Bernard A.
Ghobrial, Irene M.
Colditz, Graham A.
Giovannucci, Edward L.
Birmann, Brenda M.
INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (07) : 1823 - 1830
[44] Prognostic factors and survival in elderly patients with multiple myeloma
Rodon, P
Gauvain, JB
Linassier, C
Benboubker, L
Levallois, D
Maigre, M
Goupille, P
Luthier, F
Lucas, V
Dugay, J
Colombat, P
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 354 - 354
[45] Education level as a predictor of survival in patients with multiple myeloma
Limei Xu
Xiuju Wang
Xueyi Pan
Xiaotao Wang
Qing Wang
Bingyi Wu
Jiahui Cai
Ying Zhao
Lijuan Chen
Wuping Li
Juan Li
BMC Cancer, 20
[46] Double autologous transplantation improves survival of multiple myeloma patients: Final analysis of a prospective randomized study of the "Intergroupe Francophone du Myelome" (IFM 94).
Attal, M
Harousseau, JL
Facon, T
Guilhot, F
Doyen, C
Fuzibet, JG
Monconduit, M
Hullen, C
Caillot, D
Bouabdallah, R
Voillat, L
Sotto, JJ
Grosbois, B
Bataille, R
BLOOD, 2002, 100 (11) : 5A - 6A
[47] Survival of Patients with Multiple Myeloma Diagnosed with Second Primary Malignancies: An ASCO Cancerlinq Analysis
Cooper, John D.
Thornton, Jennifer A.
Gibson, Steven J.
Pham, Kevin
Sunderland, Kevin
DeStefano, Christin B.
BLOOD, 2022, 140 : 10039 - 10040
[48] Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Richardson, Paul G.
Kumar, Shaji K.
Masszi, Tamas
Grzasko, Norbert
Bahlis, Nizar J.
Hansson, Markus
Pour, Ludek
Sandhu, Irwindeep
Ganly, Peter
Baker, Bartrum W.
Jackson, Sharon R.
Stoppa, Anne-Marie
Gimsing, Peter
Garderet, Laurent
Touzeau, Cyrille
Buadi, Francis K.
Laubach, Jacob P.
Cavo, Michele
Darif, Mohamed
Labotka, Richard
Berg, Deborah
Moreau, Philippe
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (22) : 2430 - +
[49] When to test MYC rearrangement in multiple myeloma patients
Kebe, Ana Doplihar
Cibej, Hermina
Nussdorfer, Judita
Zver, Samo
Podgornik, Helena
MOLECULAR CYTOGENETICS, 2019, 12
[50] Prognostic impact of chromosomal abnormalities in elderly patients with multiple myeloma - final analysis of the DSMM II trial
Liebisch, P.
Straka, C.
Langer, C.
Hinke, A.
Ibach, S.
Doehner, H.
ONKOLOGIE, 2010, 33 : 94 - 94

← 1 2 3 4 5 →